UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Trastuzumab emtansine (T-DM1) versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer and central nervous system metastases: a retrospective, exploratory analysis in EMILIA

Annals of oncology, 2015-01, Vol.26 (1), p.113-119

2015

Volltextzugriff (PDF)

Effectiveness of a standardized patient education program on therapy-related side effects and unplanned therapy interruptions in oral cancer therapy: a cluster-randomized controlled trial

Supportive care in cancer, 2017-11, Vol.25 (11), p.3475-3483

2017

Volltextzugriff (PDF)

A randomized, double-blind, multicenter, phase 2 study of a human monoclonal antibody to human αν integrins (intetumumab) in combination with docetaxel and prednisone for the first-line treatment of patients with metastatic castration-resistant prostate cancer

Annals of oncology, 2013-02, Vol.24 (2), p.329-336

2013

Volltextzugriff (PDF)

Palbociclib in combination with letrozole as first or later line therapy for patients with locally advanced, inoperable or metastatic HR+/HER2- breast cancer in Germany: Interim results of the INGE-B phase II study

Annals of oncology, 2018-10, Vol.29, p.viii111-viii111

2018

Volltextzugriff (PDF)

Cetuximab in combination with platinum-based chemotherapy or radiotherapy in patients with recurrent and/or metastatic SSCHN in clinical routine: Updated interim results of the prospective SOCCER study

Annals of oncology, 2018-10, Vol.29, p.viii379-viii380

2018

Volltextzugriff (PDF)

P1171: REFLECT: PROSPECTIVE NON‐INTERVENTIONAL STUDY ON THE EFFECTIVENESS AND SAFETY OF SANDOZ RITUXIMAB (SDZ‐RTX) WITH CHOP FOR PATIENTS WITH PREVIOUSLY UNTREATED CD20‐POSITIVE DIFFUSE LARGE B‐CELL LYMPHOMA

HemaSphere, 2022-06, Vol.6 (Suppl), p.1057-1058

2022

Volltextzugriff (PDF)

The impact of allogeneic stem cell transplantation on the natural course of poor-risk chronic lymphocytic leukemia as defined by the EBMT consensus criteria: a retrospective donor versus no donor comparison

Annals of oncology, 2014-01, Vol.25 (1), p.200-206

2014

Volltextzugriff (PDF)

mFOLFOX6 versus mFOLFOX6 + aflibercept as neoadjuvant treatment in MRI-defined T3-rectal cancer: a randomized phase-II-trial of the German Rectal Cancer Study Group (CAO/ARO/AIO 0214)

ESMO open, 2024-09, Vol.9 (9), p.103703, Article 103703

2024

Volltextzugriff (PDF)

SANDOZ RITUXIMAB FOR TREATMENT OF DIFFUSE LARGE B‐CELL LYMPHOMA: INTERIM SAFETY RESULTS OF THE NON‐INTERVENTIONAL, OBSERVATIONAL, MULTICENTER, OPEN‐LABEL REFLECT STUDY

Hematological oncology, 2019-06, Vol.37 (S2), p.444-445

2019

Volltextzugriff (PDF)

P636: REAL WORLD OUTCOME WITH IBRUTINIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA FROM THE GERMAN REALITY STUDY

HemaSphere, 2022-06, Vol.6, p.534-535

2022

Volltextzugriff (PDF)

Efficacy, safety and quality-of-life data from patients with pre-treated metastatic colorectal cancer receiving trifluridine/tipiracil: results of the TALLISUR trial

ESMO open, 2022-02, Vol.7 (1), p.100391-100391, Article 100391

2022

Volltextzugriff (PDF)

Impact of trastuzumab treatment beyond disease progression for advanced/metastatic breast cancer on survival – Results from a prospective, observational study in Germany

Breast (Edinburgh), 2014-10, Vol.23 (5), p.603-608

2014

Volltextzugriff (PDF)

Patient-reported outcomes predict survival and adverse events following anticancer treatment initiation in advanced HER2-positive breast cancer

ESMO open, 2022-06, Vol.7 (3), p.100475, Article 100475

2022

Volltextzugriff (PDF)

Geopolitics in the ESC: Comparing Russias and Ukraines use of cultural diplomacy in the Eurovision Song Contest

New perspectives (Prague, Czech Republic), 2024-03, Vol.32 (1), p.5-29

2024

Volltextzugriff (PDF)

5072 POSTER First-Line Bevacizumab (Bev) Combined With Paclitaxel (pac) in Older Patients (pts) Treated for HER2-Negative Metastatic Breast Cancer (mBC) in a Routine Oncology Practice Study

European journal of cancer (1990), 2011, Vol.47, p.S351-S352

2011

Volltextzugriff (PDF)

eHealth Strategy for Elderly Patients (eStEP)

Geburtshilfe und Frauenheilkunde, 2016, Vol.76 (10)

2016

Volltextzugriff (PDF)

Bendamustine Plus Rituximab Is Effective and Has a Favorable Toxicity Profile in the Treatment of Mantle Cell and Low-Grade Non-Hodgkin's Lymphoma

Journal of clinical oncology, 2005-05, Vol.23 (15), p.3383-3389

2005

Volltextzugriff (PDF)

802P Real-world data of olaparib maintenance therapy in patients with BRCA-mutated platinum-sensitive relapsed ovarian cancer: Final results of the C-PATROL study

Annals of oncology, 2023-10, Vol.34, p.S535-S536

2023

Volltextzugriff (PDF)

Interim results of the non-interventional C-PATROL study: Real-world treatment data from patients who switched from olaparib capsules to tablets

Gynecologic oncology, 2020-10, Vol.159, p.119-120

2020

Volltextzugriff (PDF)

Palbociclib plus fulvestrant as first-line therapy for patients with locally advanced, inoperable or metastatic HR+/HER2- breast cancer in Germany: Interim results of the INGE-B phase II study

Annals of oncology, 2019-05, Vol.30, p.iii50-iii50

2019

Volltextzugriff (PDF)

Patientenkompetenz in der oralen Krebstherapie bei niedergelassenen Hämatologen und Onkologen – Eine Untersuchung zur Erfassung des Managements in der oralen antineoplastischen Therapie (Phase A) und zur Evaluation eines Schulungsmoduls zur Optimierung der Patientenunterstützung (Phase B)

Deutsche medizinische Wochenschrift, 2012, Vol.137 (S 03)

2012

Volltextzugriff (PDF)

PCN508 A COMPARISON OF PATIENT CHARACTERISTICS TREATED WITH NIVOLUMAB FOR RECURRENT/METASTATIC (R/M) SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN) IN GERMANY AND THE USA

Value in health, 2019-11, Vol.22, p.S536

2019

Volltextzugriff (PDF)

304P Incidence and resolution of eribulin-induced peripheral neuropathy (IRENE) in patients with locally advanced or metastatic breast cancer

Annals of oncology, 2021-09, Vol.32, p.S496-S497

2021

Volltextzugriff (PDF)

Olaparib in German routine clinical practice: Updated interim results of the non-interventional study c-patrol

Gynecologic oncology, 2018-06, Vol.149, p.120-120

2018

Volltextzugriff (PDF)

eHealth Strategy for Elderly Patients (eStEP)

Senologie (Stuttgart), 2016, Vol.13 (2)

2016

Volltextzugriff (PDF)

1 – 25 von 102

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(95)
Mit Volltextzugriff
(86)

Publikationsform

Artikel
(95)
Tagungsberichte
(7)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(29)
Science & Technology
(27)
Life Sciences & Biomedicine
(26)
Middle Aged
(23)
Female
(22)
Aged
(19)
Male
(18)
Adult
(17)
Oncology
(17)
Disease-Free Survival
(11)
Biological And Medical Sciences
(9)
Medical Sciences
(9)
Aged, 80 And Over
(8)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(8)
Chemotherapy
(7)
Follow-Up Studies
(7)
Hematology, Oncology And Palliative Medicine
(7)
Prospective Studies
(7)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(6)
Breast Neoplasms - Pathology
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Trastuzumab emtansine (T-DM1) versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer and central nervous system metastases: a retrospective, exploratory analysis in EMILIA

Effectiveness of a standardized patient education program on therapy-related side effects and unplanned therapy interruptions in oral cancer therapy: a cluster-randomized controlled trial

A randomized, double-blind, multicenter, phase 2 study of a human monoclonal antibody to human αν integrins (intetumumab) in combination with docetaxel and prednisone for the first-line treatment of patients with metastatic castration-resistant prostate cancer

Palbociclib in combination with letrozole as first or later line therapy for patients with locally advanced, inoperable or metastatic HR+/HER2- breast cancer in Germany: Interim results of the INGE-B phase II study

Cetuximab in combination with platinum-based chemotherapy or radiotherapy in patients with recurrent and/or metastatic SSCHN in clinical routine: Updated interim results of the prospective SOCCER study

P1171: REFLECT: PROSPECTIVE NON‐INTERVENTIONAL STUDY ON THE EFFECTIVENESS AND SAFETY OF SANDOZ RITUXIMAB (SDZ‐RTX) WITH CHOP FOR PATIENTS WITH PREVIOUSLY UNTREATED CD20‐POSITIVE DIFFUSE LARGE B‐CELL LYMPHOMA

The impact of allogeneic stem cell transplantation on the natural course of poor-risk chronic lymphocytic leukemia as defined by the EBMT consensus criteria: a retrospective donor versus no donor comparison

mFOLFOX6 versus mFOLFOX6 + aflibercept as neoadjuvant treatment in MRI-defined T3-rectal cancer: a randomized phase-II-trial of the German Rectal Cancer Study Group (CAO/ARO/AIO 0214)

SANDOZ RITUXIMAB FOR TREATMENT OF DIFFUSE LARGE B‐CELL LYMPHOMA: INTERIM SAFETY RESULTS OF THE NON‐INTERVENTIONAL, OBSERVATIONAL, MULTICENTER, OPEN‐LABEL REFLECT STUDY

P636: REAL WORLD OUTCOME WITH IBRUTINIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA FROM THE GERMAN REALITY STUDY

Efficacy, safety and quality-of-life data from patients with pre-treated metastatic colorectal cancer receiving trifluridine/tipiracil: results of the TALLISUR trial

Impact of trastuzumab treatment beyond disease progression for advanced/metastatic breast cancer on survival – Results from a prospective, observational study in Germany

Patient-reported outcomes predict survival and adverse events following anticancer treatment initiation in advanced HER2-positive breast cancer

Geopolitics in the ESC: Comparing Russias and Ukraines use of cultural diplomacy in the Eurovision Song Contest

5072 POSTER First-Line Bevacizumab (Bev) Combined With Paclitaxel (pac) in Older Patients (pts) Treated for HER2-Negative Metastatic Breast Cancer (mBC) in a Routine Oncology Practice Study

eHealth Strategy for Elderly Patients (eStEP)

Bendamustine Plus Rituximab Is Effective and Has a Favorable Toxicity Profile in the Treatment of Mantle Cell and Low-Grade Non-Hodgkin's Lymphoma

802P Real-world data of olaparib maintenance therapy in patients with BRCA-mutated platinum-sensitive relapsed ovarian cancer: Final results of the C-PATROL study

Interim results of the non-interventional C-PATROL study: Real-world treatment data from patients who switched from olaparib capsules to tablets

Palbociclib plus fulvestrant as first-line therapy for patients with locally advanced, inoperable or metastatic HR+/HER2- breast cancer in Germany: Interim results of the INGE-B phase II study

Patientenkompetenz in der oralen Krebstherapie bei niedergelassenen Hämatologen und Onkologen – Eine Untersuchung zur Erfassung des Managements in der oralen antineoplastischen Therapie (Phase A) und zur Evaluation eines Schulungsmoduls zur Optimierung der Patientenunterstützung (Phase B)

PCN508 A COMPARISON OF PATIENT CHARACTERISTICS TREATED WITH NIVOLUMAB FOR RECURRENT/METASTATIC (R/M) SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN) IN GERMANY AND THE USA

304P Incidence and resolution of eribulin-induced peripheral neuropathy (IRENE) in patients with locally advanced or metastatic breast cancer

Olaparib in German routine clinical practice: Updated interim results of the non-interventional study c-patrol

eHealth Strategy for Elderly Patients (eStEP)

Suchergebnisse filtern